Update From the First-in-Human Study With the Novel DurAVR Biomimetic Transcatheter Heart Valve—Coverage of SCAI Scientific Sessions 2024 Read more about Update From the First-in-Human Study With the Novel DurAVR Biomimetic Transcatheter Heart Valve—Coverage of SCAI Scientific Sessions 2024
Cardiac Catheterization With Liberal Oral Intake: The CALORI Trial—Coverage of SCAI Scientific Sessions 2024 Read more about Cardiac Catheterization With Liberal Oral Intake: The CALORI Trial—Coverage of SCAI Scientific Sessions 2024
Preventive PCI or Medical Therapy Alone For Atherosclerotic Coronary Vulnerable Plaques—Coverage of ACC 2024 Read more about Preventive PCI or Medical Therapy Alone For Atherosclerotic Coronary Vulnerable Plaques—Coverage of ACC 2024
Fractional Flow Reserve-guided Complete or Culprit-only PCI in Patients With ST-elevation Myocardial Infarction—Coverage of ACC 2024 Read more about Fractional Flow Reserve-guided Complete or Culprit-only PCI in Patients With ST-elevation Myocardial Infarction—Coverage of ACC 2024
Ultrasound-Assisted versus Standard Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: Insights From National Inpatient Sample—Coverage of ACC 2024 Read more about Ultrasound-Assisted versus Standard Catheter-Directed Thrombolysis for Acute Pulmonary Embolism: Insights From National Inpatient Sample—Coverage of ACC 2024
Percutaneous Transvalvular Micro-Axial Flow Pump in Infarct Related Cardiogenic Shock: Results of the DANGER-SHOCK Trial—Coverage of ACC 2024 Read more about Percutaneous Transvalvular Micro-Axial Flow Pump in Infarct Related Cardiogenic Shock: Results of the DANGER-SHOCK Trial—Coverage of ACC 2024
Coronary Sinus Reducer For the Treatment of Refractory Angina: A Randomized, Placebo-Controlled Trial (ORBITA-COSMIC)—Coverage of ACC 2024 Read more about Coronary Sinus Reducer For the Treatment of Refractory Angina: A Randomized, Placebo-Controlled Trial (ORBITA-COSMIC)—Coverage of ACC 2024
Temporal Trends in Transcatheter Aortic Valve Replacement for Isolated Severe Aortic Stenosis—Coverage of ACC 2024 Read more about Temporal Trends in Transcatheter Aortic Valve Replacement for Isolated Severe Aortic Stenosis—Coverage of ACC 2024
One Year Performance of the Navitor Transcatheter Heart Valve in TAVR Read more about One Year Performance of the Navitor Transcatheter Heart Valve in TAVR
Four-Year Outcomes from the Evolut Low Risk Trial with Contemporary SAVR Read more about Four-Year Outcomes from the Evolut Low Risk Trial with Contemporary SAVR
